Professor Anthony Heagerty (Professor of Medicine and Cardiac Centre Lead, Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK) discusses the recent update to the ESC/ESH Guidelines which released in Barcelona, Spain in June 2018.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Professor Anthony Heagerty has nothing to disclose in relation to this video interview.
1. Please can you outline the most important updates to the ESC/ESH Guidelines? (0:08)
2. What was the response to the “first look” at the new guidelines at the ESH Congress in Barcelona in June? (0:54)
3. Please describe the rationale for the unchanged classification of hypertension in the new ESC/ESH Guidelines compared with the revised classification of hypertension in the ACC/AHA Hypertension Guidelines? (1:33)
4. What impact do you think these updates will have on patients, particularly older patients for whom the hypertension threshold and blood pressure treatment targets are now lower than in the previous guidelines? (2:43)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Hypertension
Clara Chow, ESC 2021 – the QUARTET Study
Dr Clara Chow (Professor of Medicine, Academic Director Westmead Applied Research Centre, University of Sydney, Sydney, Australia) kindly shared her thoughts on the limitations of current treatment paradigms for hypertension, the quad pill for hypertension, and the QUARTET study, from the virtual ESC Congress 2021. Questions What are the limitations of current treatment paradigms for […]
Kazem Rahimi, ESC 2021 – the Blood Pressure Lowering Treatment Trialists Collaboration
Dr Kazem Rahimi (Professor of Cardiovascular Medicine and Population Health, University of Oxford, Oxford, UK) kindly shared his thoughts on the Blood Pressure Lowering Treatment Trialists Collaboration (BPLTTC), its aims, and the benefits of antihypertensive medicines in older people from the virtual ESC Congress 2021. Questions Could you tell us a little about the Blood […]
Kazuomi Kario, ESC 2021 – the HERB Digital Therapeutics System and the HERB-DH1 Study
Prof. Kazuomi Kario (Professor, Jichi Medical University, Shimotsuke, Tochigi, Japan) kindly shared his thoughts on the HERB digital therapeutics system for essential hypertension and the HERB-DH1 study from the virtual ESC Congress 2021. Questions Could you give us a brief overview of the HERB digital therapeutics system for essential hypertension? (0.14) What were the aims, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!